Hillevax

Developer of a vaccine for norovirus infection

placeBoston, Massachusetts, United States calendar_todayFounded 2021 groups62 employees language hillevax.com

Registered entities

Investor mix

13 investors on record; lead investors include Frazier Healthcare Partners.

Investor typeCountShare
Venture capital754%
Private equity18%
Bank & private debt18%
Other / undisclosed431%
Coming soon